Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
D L LongoR C Young

Abstract

To review the efficacy of cyclophosphamide, doxorubicin, etoposide, methotrexate with leucovorin, and prednisone (ProMACE)-based combination chemotherapy programs in the treatment of patients with diffuse small noncleaved-cell non-Burkitt's lymphoma. Thirty-three patients with diffuse small noncleaved-cell non-Burkitt's lymphoma were accrued: eight with localized disease were treated with modified ProMACE-mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) plus involved-field radiation therapy, and 25 with advanced-stage disease were treated with ProMACE/MOPP flexitherapy (n = 8), ProMACE-MOPP (n = 9), or ProMACE-cytarabine, bleomycin, vincristine, and methotrexate with leucovorin (CytaBOM) (n = 8). The median follow-up duration is 10 years. All eight patients with localized disease achieved a complete response, none have relapsed, and one died of intercurrent illness. Among patients with advanced-stage disease, five of eight (63%) flexitherapy-treated patients, six of nine (67%) ProMACE-MOPP-treated patients, and eight of eight (100%) ProMACE-CytaBOM-treated patients achieved a complete response. If the two ProMACE-MOPP-based groups are considered together, disease-free and overall survival rates at 15 years are ...Continue Reading

Citations

Oct 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E J LeeB A Peterson
Dec 18, 2008·British Journal of Haematology·Jessica HochbergMitchell S Cairo
Sep 24, 2015·Terapevticheskiĭ arkhiv·E A BaryakhS K Kravchenko
Oct 3, 1999·Current Opinion in Oncology·A Sarris, R Ford
Apr 1, 2005·Leukemia·G W van ImhoffUNKNOWN Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)
Jul 22, 2004·Blood·Kristie A BlumJohn C Byrd
Nov 15, 2013·The New England Journal of Medicine·Kieron DunleavyWyndham H Wilson
Jul 27, 2000·Obstetrics and Gynecology·K W Windom, R S McDuffie
Aug 18, 2004·Current Opinion in Oncology·Yvette L Kasamon, Lode J Swinnen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.